Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)

NCT05615922 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT05615922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05615922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
December 24, 2022
Completion date
August 14, 2023
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary progressive aphasia